Pharmaceutical Giant Egis Expands Körmend Facility The government will continue to provide every support to ensure that the Hungarian pharmaceutical industry remains at the forefront of... 2025.07.29.
Government Secures Expansion Pledges from French Business Giants Christophe Périllat (L), CEO of Valeo automotive supplier and technology company and Jean-Luc di Paola-Galloni, Valeo's Vice President for Sustainability... 2025.07.25.
14 Million Euro Investment Boosts Domestic Pharmaceutical Machinery Industry Despite a general slowdown in the machinery industry, the pharmaceutical machinery sector continues to grow, with a 6–7% annual increase... 2025.07.24.
German Pharma Tech Giant Schott to Start Another 100 Billion Investment The Hungarian economy is once again strengthening in a strategic sector, with developments affecting the medical technology and pharmaceutical industries,... 2025.06.05.
Government Targets Pharmaceuticals in Latest Fight against High Prices The Minister for National Economy shared a post on his Facebook page highlighting the fact that the price of unsubsidized... 2025.05.22.
Richter Signs Development Agreement for Weight Loss Jab Gedeon Richter Plc. and Adalvo, a pharmaceutical company, have entered into a strategic joint development and licensing agreement for the... 2025.05.07.
Two Richter Products Recommended for Marketing Authorization Gedeon Richter Plc. received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European... 2025.04.28.
Richter Applies for Authorization of Drug Suitable for Treatment of COVID-19 Gedeon Richter’s headquarters in Budapest Gedeon Richter Plc. has submitted a marketing authorization application (MAA) to the European Medicines Agency... 2025.03.28.
Pharmaceutical Company Contributes HUF 100 Million to Science Education The Centenary Foundation of Gedeon Richter Plc is supporting science education improvement in public schools with a HUF 100 million... 2025.02.25.
Richter’s Popular Drug Subject to Price Cuts by US Regulators The antipsychotic Vraylar, developed by the Hungarian pharmaceutical company Gedeon Richter, has landed on a list of drugs whose prices... 2025.01.21.
HUN-REN Development Benefits Both Pharmaceutical and Agricultural Industries The Organocatalysis Research Group at the HUN-REN Research Center for Natural Sciences (HUN-REN RCNS) has achieved a groundbreaking advance in... 2025.01.21.
FDA Accepts Richter’s Marketing Authorization for Denosumab Biosimilars The U.S. Food and Drug Administration (FDA) has accepted the application submitted by Gedeon Richter and Hikma for the approval... 2024.12.13.
Pharmaceutical Industry is Key to Economic Growth and Competitiveness Minister for National Economy Márton Nagy delivered the opening speech of the conference "The Competitiveness of the European and Hungarian... 2024.11.27.
Richter Sees Robust Sales Fueled by Pharma Revenue Gedeon Richter’s headquarters in Budapest. Consolidated sales of Gedeon Richter amounted to HUF 636.4 billion (EUR 1.5 billion) in the... 2024.11.13.
Olivér Várhelyi Advocates for Revitalizing EU Pharmaceutical Production Olivér Várhelyi, Hungary’s EU Commissioner-designate for Health and Animal Welfare, recently participated in a hearing before the European Parliament’s competent... 2024.11.07.
Richter Announces Collaboration with U.S. Pharmaceutical Company Richter Gedeon’s headquarters in Budapest Budapest-based pharmaceutical giant Richter announced a new research and development collaboration in the field of... 2024.10.25.
Richter’s Female Health Product to Be Marketed in Japan Gedeon Richter Plc.'s partner, Fuji Pharma Co., Ltd. has received marketing approval for the combination tablet Alyssa, developed in Japan.... 2024.09.25.
Richter Inaugurates World-leading Production Facility for the Global Market Richter Gedeon's headquarters in Budapest Richter BioLogics GmbH & CoKG, the microbial biologics affiliate of Richter Gedeon, inaugurated a new... 2024.09.17.
Surprising Target Price Set for Pharmaceutical Giant Richter’s Shares In a few years, Gedeon Richter Plc's revenue could rise by 50 percent, according to MBH Bank, that started tracking... 2024.09.11.
Pharmaceutical Company Gedeon Richter Reports Robust First Half of 2024 In the first half of 2024, Gedeon Richter reported consolidated revenue of HUF 419.69B (EUR 1.05B), a 1.5 percent increase... 2024.08.06.
1B Export Surplus Despite Trade Slowdown In May, Hungary's trade surplus in goods was EUR 1.0 billion, down EUR 218M from last year, according to the... 2024.08.01.